Butodesnitazene

Butodesnitazene
Identifiers
	IUPAC name 2-[(4-Butoxyphenyl)methyl]-1-(2-diethylaminoethyl)benzimidazole;
Chemical and physical data
Formula	C24H33N3O
Molar mass	379.548 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCn1c(nc2ccccc12)Cc1ccc(OCCCC)cc1;
	InChI InChI=InChI=1S/C24H33N3O/c1-4-7-18-28-21-14-12-20(13-15-21)19-24-25-22-10-8-9-11-23(22)27(24)17-16-26(5-2)6-3/h8-15H,4-7,16-19H2,1-3H3; Key:NOCZAWHIDDFBFO-UHFFFAOYSA-N;

Butodesnitazene is a benzimidazole derivative with opioid effects, which has been sold as a designer drug. It was identified by drug checking services in New Zealand in 2025, having been sold on the black market misrepresented as heroin. Its pharmacological properties have not been studied, although based on the known structure-activity relationships of the benzimidazole opioids, it is expected to have comparatively low potency.^[1]

References

↑ Mayer A, Montgomery N, Hughes E, Birks Ang B, Johnson OE (February 2026). "Detection and characterisation of a new nitazene analogue, butodesnitazene: A collaborative approach to the identification of novel psychoactive substances through Drug Checking". Forensic Science International. 378 112717. doi:10.1016/j.forsciint.2025.112717. PMID 41240498.

This analgesic-related article is a stub. You can help Wikipedia by adding missing information.

[Mayer_2026-1] Mayer A, Montgomery N, Hughes E, Birks Ang B, Johnson OE (February 2026). "Detection and characterisation of a new nitazene analogue, butodesnitazene: A collaborative approach to the identification of novel psychoactive substances through Drug Checking". Forensic Science International. 378 112717. doi:10.1016/j.forsciint.2025.112717. PMID 41240498.

[1]

This page was redesigned at the edge.

A page that knows where it met you.

Butodesnitazene

See also

References